116 related articles for article (PubMed ID: 12385679)
21. Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.
Knapp JS; Wongba C; Limpakarnjanarat K; Young NL; Parekh MC; Neal SW; Buatiang A; Chitwarakorn A; Mastro TD
Sex Transm Dis; 1997 Mar; 24(3):142-8. PubMed ID: 9132980
[TBL] [Abstract][Full Text] [Related]
22. Gonococcal susceptibility to antimicrobials in Baltimore, 1988-1994. What was the impact of ciprofloxacin as first-line therapy for gonorrhea?
Zenilman JM
Sex Transm Dis; 1996; 23(3):213-8. PubMed ID: 8724511
[TBL] [Abstract][Full Text] [Related]
23. Importation into the UK of a strain of Neisseria gonorrhoeae resistant to penicillin, ciprofloxacin and tetracycline.
Turner A; Gough KR; Jephcott AE; McClean AN
Genitourin Med; 1995 Oct; 71(5):331-2. PubMed ID: 7490059
[No Abstract] [Full Text] [Related]
24. Antibiotic susceptibility pattern of gonococcal isolates.
Jain SK; Kulkarni MG; Banker DD
Indian J Med Sci; 1994 Oct; 48(10):233-6. PubMed ID: 7829173
[TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy and safety of single oral doses of sparfloxacin versus ciprofloxacin in the treatment of acute gonococcal urethritis in men.
Moi H; Morel P; Gianotti B; Barlow D; Phillips I; Jean C
J Antimicrob Chemother; 1996 May; 37 Suppl A():115-22. PubMed ID: 8737131
[TBL] [Abstract][Full Text] [Related]
26. Comparative trial of single-dose ciprofloxacin and ampicillin plus probenecid for treatment of gonococcal urethritis in men.
Roddy RE; Handsfield HH; Hook EW
Antimicrob Agents Chemother; 1986 Aug; 30(2):267-9. PubMed ID: 3094439
[TBL] [Abstract][Full Text] [Related]
27. Gonococcal resistance: evolving from penicillin, tetracycline to the quinolones in South Africa -- implications for treatment guidelines.
De Jongh M; Dangor Y; Adam A; Hoosen AA
Int J STD AIDS; 2007 Oct; 18(10):697-9. PubMed ID: 17945048
[TBL] [Abstract][Full Text] [Related]
28. Fluoroquinolone treatment failure in gonorrhea. Emergence of a Neisseria gonorrhoeae strain with enhanced resistance to fluoroquinolones.
Deguchi T; Saito I; Tanaka M; Sato K; Deguchi K; Yasuda M; Nakano M; Nishino Y; Kanematsu E; Ozeki S; Kawada Y
Sex Transm Dis; 1997 May; 24(5):247-50. PubMed ID: 9153731
[TBL] [Abstract][Full Text] [Related]
29. [Bacteriological and clinical study of ciprofloxacin in gonococcal urethritis].
Okazaki T; Kiyota H; Gotoh H; Onodera
Jpn J Antibiot; 1986 Oct; 39(10):2685-9. PubMed ID: 3100837
[TBL] [Abstract][Full Text] [Related]
30. Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007.
Brown LB; Krysiak R; Kamanga G; Mapanje C; Kanyamula H; Banda B; Mhango C; Hoffman M; Kamwendo D; Hobbs M; Hosseinipour MC; Martinson F; Cohen MS; Hoffman IF
Sex Transm Dis; 2010 Mar; 37(3):169-72. PubMed ID: 19901860
[TBL] [Abstract][Full Text] [Related]
31. Emergence of ciprofloxacin resistant Neisseria gonorrhoeae in north India.
Sethi S; Sharma D; Mehta SD; Singh B; Smriti M; Kumar B; Sharma M
Indian J Med Res; 2006 May; 123(5):707-10. PubMed ID: 16873916
[TBL] [Abstract][Full Text] [Related]
32. Ciprofloxacin resistance in Neisseria gonorrhoeae: trends in Hawaii, 1997-2002.
Katz AR; Lee MV; Ohye RG; Whiticar PM; Effler PV
Lancet; 2003 Aug; 362(9382):495. PubMed ID: 12927447
[No Abstract] [Full Text] [Related]
33. Typing of Neisseria gonorrhoeae reveals rapid reinfection in rural South Africa.
Moodley P; Martin IM; Ison CA; Sturm AW
J Clin Microbiol; 2002 Dec; 40(12):4567-70. PubMed ID: 12454153
[TBL] [Abstract][Full Text] [Related]
34. Comparison of ciprofloxacin and ceftriaxone as single-dose therapy for uncomplicated gonorrhea in women.
Hook EW; Jones RB; Martin DH; Bolan GA; Mroczkowski TF; Neumann TM; Haag JJ; Echols R
Antimicrob Agents Chemother; 1993 Aug; 37(8):1670-3. PubMed ID: 8215281
[TBL] [Abstract][Full Text] [Related]
35. Fleroxacin versus standard therapy in gonococcal urethritis.
Lassus A; Renkonen OV; Ellmén J
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():223-5. PubMed ID: 3144542
[TBL] [Abstract][Full Text] [Related]
36. Ciprofloxacin resistant Neisseria gonorrhoeae.
Thompson C; Young H; Moyes A
Genitourin Med; 1995 Dec; 71(6):412-3. PubMed ID: 8566988
[No Abstract] [Full Text] [Related]
37. Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada.
Ng LK; Sawatzky P; Martin IE; Booth S
Sex Transm Dis; 2002 Dec; 29(12):780-8. PubMed ID: 12466720
[TBL] [Abstract][Full Text] [Related]
38. Gonorrhoea treatment failure and ciprofloxacin resistance.
Ng PP; Chan RK; Ling AE
Int J STD AIDS; 1998 Jun; 9(6):323-5. PubMed ID: 9671244
[TBL] [Abstract][Full Text] [Related]
39. Development of in-vivo resistance after quinolone treatment of gonococcal urethritis.
Vila J; Olmos L; Ballesteros J; Vázquez JA; Giménez MJ; Marco F; Aguilar L
J Antimicrob Chemother; 1997 Jun; 39(6):841. PubMed ID: 9222062
[No Abstract] [Full Text] [Related]
40. Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam.
Mbwana J; Mhalu F; Mwakagile D; Masesa J; Moshiro C; Sandstrom E
East Afr Med J; 1999 Jun; 76(6):330-4. PubMed ID: 10750520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
